Does the media refer more to DOX or CTSH?

In the previous week, Cognizant Technology Solutions had 13 more articles in the media than Amdocs. MarketBeat recorded 25 mentions for Cognizant Technology Solutions and 12 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.15 beat Amdocs' score of 0.80 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cognizant Technology Solutions 14 Very Positive mention(s) 6 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ACN or DOX?

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Accenture $69.67B 1.60 $7.68B $12.21 13.73 Amdocs $4.53B 1.33 $564.70M $5.00 11.20

Is ACN or DOX more profitable?

Amdocs has a net margin of 11.81% compared to Accenture's net margin of 10.61%. Accenture's return on equity of 26.33% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Accenture 10.61% 26.33% 12.94% Amdocs 11.81% 19.77% 10.87%

Does the media refer more to ACN or DOX?

In the previous week, Accenture had 34 more articles in the media than Amdocs. MarketBeat recorded 46 mentions for Accenture and 12 mentions for Amdocs. Accenture's average media sentiment score of 0.89 beat Amdocs' score of 0.80 indicating that Accenture is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accenture 30 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, DOX or LDOS?

Leidos has higher revenue and earnings than Amdocs. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amdocs $4.53B 1.33 $564.70M $5.00 11.20 Leidos $17.17B 0.89 $1.45B $10.92 11.18

Is DOX or LDOS more profitable?

Amdocs has a net margin of 11.81% compared to Leidos' net margin of 8.15%. Leidos' return on equity of 31.92% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Amdocs 11.81% 19.77% 10.87% Leidos 8.15% 31.92% 11.23%

Does the media favor DOX or LDOS?

In the previous week, Leidos had 5 more articles in the media than Amdocs. MarketBeat recorded 17 mentions for Leidos and 12 mentions for Amdocs. Leidos' average media sentiment score of 0.94 beat Amdocs' score of 0.80 indicating that Leidos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Leidos 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to DOX or CACI?

In the previous week, Amdocs had 7 more articles in the media than CACI International. MarketBeat recorded 12 mentions for Amdocs and 5 mentions for CACI International. Amdocs' average media sentiment score of 0.80 beat CACI International's score of 0.47 indicating that Amdocs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CACI International 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, IT or DOX?

Gartner has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gartner $6.50B 1.53 $729.23M $10.12 14.67 Amdocs $4.53B 1.33 $564.70M $5.00 11.20

Is IT or DOX more profitable?

Amdocs has a net margin of 11.81% compared to Gartner's net margin of 11.44%. Gartner's return on equity of 161.39% beat Amdocs' return on equity. Company Net Margins Return on Equity Return on Assets Gartner 11.44% 161.39% 12.74% Amdocs 11.81% 19.77% 10.87%

Does the media prefer IT or DOX?

In the previous week, Amdocs had 2 more articles in the media than Gartner. MarketBeat recorded 12 mentions for Amdocs and 10 mentions for Gartner. Amdocs' average media sentiment score of 0.80 beat Gartner's score of 0.24 indicating that Amdocs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gartner 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Amdocs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Amdocs (DOX) Competitors

$56.01 -0.96 (-1.69%)

Closing price 03:59 PM Eastern

Extended Trading

$56.01 +0.00 (+0.00%)

As of 05:51 PM Eastern

Compare

DOX vs. CTSH, ACN, LDOS, CACI, and IT

Should you buy Amdocs stock or one of its competitors? MarketBeat compares Amdocs with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Amdocs include Cognizant Technology Solutions (CTSH), Accenture (ACN), Leidos (LDOS), CACI International (CACI), and Gartner (IT). These companies are all part of the "it consulting & other services" industry.

How does Amdocs compare to Cognizant Technology Solutions?

Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Cognizant Technology Solutions had 13 more articles in the media than Amdocs. MarketBeat recorded 25 mentions for Cognizant Technology Solutions and 12 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.15 beat Amdocs' score of 0.80 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cognizant Technology Solutions	14 Very Positive mention(s)	6 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Amdocs has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Comparatively, Cognizant Technology Solutions has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.1%. Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.6%. Amdocs pays out 45.6% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has raised its dividend for 14 consecutive years and Cognizant Technology Solutions has raised its dividend for 6 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.33	$564.70M	$5.00	11.20
Cognizant Technology Solutions	$21.11B	1.15	$2.23B	$4.60	11.13

Amdocs has a net margin of 11.81% compared to Cognizant Technology Solutions' net margin of 10.41%. Amdocs' return on equity of 19.77% beat Cognizant Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	11.81%	19.77%	10.87%
Cognizant Technology Solutions	10.41%	17.50%	12.94%

Amdocs presently has a consensus price target of $86.67, indicating a potential upside of 54.74%. Cognizant Technology Solutions has a consensus price target of $73.50, indicating a potential upside of 43.61%. Given Amdocs' higher probable upside, analysts clearly believe Amdocs is more favorable than Cognizant Technology Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cognizant Technology Solutions	0 Sell rating(s)	12 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.48

92.0% of Amdocs shares are held by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 0.4% of Cognizant Technology Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Cognizant Technology Solutions beats Amdocs on 10 of the 19 factors compared between the two stocks.

How does Amdocs compare to Accenture?

Accenture (NYSE:ACN) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Accenture has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Accenture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accenture	$69.67B	1.60	$7.68B	$12.21	13.73
Amdocs	$4.53B	1.33	$564.70M	$5.00	11.20

Accenture pays an annual dividend of $6.52 per share and has a dividend yield of 3.9%. Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.1%. Accenture pays out 53.4% of its earnings in the form of a dividend. Amdocs pays out 45.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Accenture has raised its dividend for 20 consecutive years and Amdocs has raised its dividend for 14 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Accenture had 34 more articles in the media than Amdocs. MarketBeat recorded 46 mentions for Accenture and 12 mentions for Amdocs. Accenture's average media sentiment score of 0.89 beat Amdocs' score of 0.80 indicating that Accenture is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accenture	30 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Accenture has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Amdocs has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

Amdocs has a net margin of 11.81% compared to Accenture's net margin of 10.61%. Accenture's return on equity of 26.33% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accenture	10.61%	26.33%	12.94%
Amdocs	11.81%	19.77%	10.87%

75.1% of Accenture shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 0.0% of Accenture shares are held by company insiders. Comparatively, 15.4% of Amdocs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Accenture currently has a consensus target price of $259.89, indicating a potential upside of 54.98%. Amdocs has a consensus target price of $86.67, indicating a potential upside of 54.74%. Given Accenture's stronger consensus rating and higher probable upside, research analysts plainly believe Accenture is more favorable than Amdocs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accenture	0 Sell rating(s)	10 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.63
Amdocs	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Accenture beats Amdocs on 14 of the 19 factors compared between the two stocks.

How does Amdocs compare to Leidos?

Amdocs (NASDAQ:DOX) and Leidos (NYSE:LDOS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Amdocs pays an annual dividend of $2.28 per share and has a dividend yield of 4.1%. Leidos pays an annual dividend of $1.72 per share and has a dividend yield of 1.4%. Amdocs pays out 45.6% of its earnings in the form of a dividend. Leidos pays out 15.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years and Leidos has increased its dividend for 6 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Leidos has higher revenue and earnings than Amdocs. Leidos is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.33	$564.70M	$5.00	11.20
Leidos	$17.17B	0.89	$1.45B	$10.92	11.18

Amdocs currently has a consensus price target of $86.67, suggesting a potential upside of 54.74%. Leidos has a consensus price target of $187.50, suggesting a potential upside of 53.64%. Given Amdocs' higher probable upside, equities research analysts plainly believe Amdocs is more favorable than Leidos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Leidos	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.57

In the previous week, Leidos had 5 more articles in the media than Amdocs. MarketBeat recorded 17 mentions for Leidos and 12 mentions for Amdocs. Leidos' average media sentiment score of 0.94 beat Amdocs' score of 0.80 indicating that Leidos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Leidos	12 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Amdocs has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market. Comparatively, Leidos has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market.

Amdocs has a net margin of 11.81% compared to Leidos' net margin of 8.15%. Leidos' return on equity of 31.92% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	11.81%	19.77%	10.87%
Leidos	8.15%	31.92%	11.23%

92.0% of Amdocs shares are held by institutional investors. Comparatively, 76.1% of Leidos shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 0.8% of Leidos shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Leidos beats Amdocs on 12 of the 20 factors compared between the two stocks.

How does Amdocs compare to CACI International?

Amdocs (NASDAQ:DOX) and CACI International (NYSE:CACI) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Amdocs has a net margin of 11.81% compared to CACI International's net margin of 5.86%. Amdocs' return on equity of 19.77% beat CACI International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amdocs	11.81%	19.77%	10.87%
CACI International	5.86%	15.90%	6.86%

Amdocs presently has a consensus target price of $86.67, indicating a potential upside of 54.74%. CACI International has a consensus target price of $627.82, indicating a potential upside of 19.15%. Given Amdocs' higher probable upside, analysts clearly believe Amdocs is more favorable than CACI International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amdocs	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
CACI International	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71

92.0% of Amdocs shares are held by institutional investors. Comparatively, 86.4% of CACI International shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 1.1% of CACI International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Amdocs has higher earnings, but lower revenue than CACI International. Amdocs is trading at a lower price-to-earnings ratio than CACI International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amdocs	$4.53B	1.33	$564.70M	$5.00	11.20
CACI International	$8.63B	1.35	$499.83M	$24.24	21.74

In the previous week, Amdocs had 7 more articles in the media than CACI International. MarketBeat recorded 12 mentions for Amdocs and 5 mentions for CACI International. Amdocs' average media sentiment score of 0.80 beat CACI International's score of 0.47 indicating that Amdocs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CACI International	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Amdocs has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market. Comparatively, CACI International has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

Summary

Amdocs beats CACI International on 9 of the 17 factors compared between the two stocks.

How does Amdocs compare to Gartner?

Gartner (NYSE:IT) and Amdocs (NASDAQ:DOX) are both it consulting & other services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability.

Gartner has higher revenue and earnings than Amdocs. Amdocs is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gartner	$6.50B	1.53	$729.23M	$10.12	14.67
Amdocs	$4.53B	1.33	$564.70M	$5.00	11.20

91.5% of Gartner shares are held by institutional investors. Comparatively, 92.0% of Amdocs shares are held by institutional investors. 2.6% of Gartner shares are held by company insiders. Comparatively, 15.4% of Amdocs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Amdocs had 2 more articles in the media than Gartner. MarketBeat recorded 12 mentions for Amdocs and 10 mentions for Gartner. Amdocs' average media sentiment score of 0.80 beat Gartner's score of 0.24 indicating that Amdocs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gartner	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Amdocs	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Amdocs has a net margin of 11.81% compared to Gartner's net margin of 11.44%. Gartner's return on equity of 161.39% beat Amdocs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Gartner	11.44%	161.39%	12.74%
Amdocs	11.81%	19.77%	10.87%

Gartner currently has a consensus target price of $176.70, suggesting a potential upside of 19.03%. Amdocs has a consensus target price of $86.67, suggesting a potential upside of 54.74%. Given Amdocs' stronger consensus rating and higher probable upside, analysts plainly believe Amdocs is more favorable than Gartner.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gartner	2 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Amdocs	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Gartner has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Amdocs has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

Summary

Gartner and Amdocs tied by winning 8 of the 16 factors compared between the two stocks.

Get Amdocs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DOX vs. The Competition

Export

Metric	Amdocs	IT Services Industry	Computer Sector	NASDAQ Exchange
Market Cap	$6.15B	$12.58B	$37.94B	$11.73B
Dividend Yield	4.00%	2.49%	3.16%	5.56%
P/E Ratio	11.20	42.42	164.28	22.08
Price / Sales	1.33	9.44	631.30	108.52
Price / Cash	7.27	23.79	47.91	54.62
Price / Book	1.82	3.31	9.65	6.82
Net Income	$564.70M	$534.06M	$1.07B	$337.41M
7 Day Performance	-8.01%	-4.83%	-3.01%	-0.96%
1 Month Performance	-10.49%	-2.02%	3.95%	1.68%
1 Year Performance	-40.10%	-24.14%	157.13%	26.88%

Amdocs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DOX Amdocs	4.8965 of 5 stars	$56.01 -1.7%	$86.67 +54.7%	-39.0%	$6.15B	$4.53B	11.20	26,969
CTSH Cognizant Technology Solutions	4.7564 of 5 stars	$53.40 -0.2%	$72.68 +36.1%	-36.1%	$25.30B	$21.11B	11.61	351,600	Positive News Analyst Forecast Gap Down
ACN Accenture	4.9367 of 5 stars	$178.82 +0.8%	$265.54 +48.5%	-46.8%	$118.99B	$69.67B	14.65	779,000	Upcoming Earnings Analyst Forecast
LDOS Leidos	4.8354 of 5 stars	$124.73 +0.3%	$187.50 +50.3%	-16.5%	$15.69B	$17.17B	11.42	47,000	Analyst Downgrade
CACI CACI International	3.9136 of 5 stars	$531.60 +0.7%	$627.82 +18.1%	+19.3%	$11.74B	$8.63B	21.93	25,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DOX) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amdocs (DOX) Competitors

DOX vs. CTSH, ACN, LDOS, CACI, and IT

How does Amdocs compare to Cognizant Technology Solutions?

Summary

How does Amdocs compare to Accenture?

Summary

How does Amdocs compare to Leidos?

Summary

How does Amdocs compare to CACI International?

Summary

How does Amdocs compare to Gartner?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOX vs. The Competition

Amdocs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amdocs (DOX) Competitors

DOX vs. CTSH, ACN, LDOS, CACI, and IT

How does Amdocs compare to Cognizant Technology Solutions?

Does the media refer more to DOX or CTSH?

Which has more risk & volatility, DOX or CTSH?

Is DOX or CTSH a better dividend stock?

Which has stronger earnings & valuation, DOX or CTSH?

Is DOX or CTSH more profitable?

Do analysts prefer DOX or CTSH?

Do insiders and institutionals hold more shares of DOX or CTSH?

Summary

How does Amdocs compare to Accenture?

Which has higher earnings and valuation, ACN or DOX?

Is ACN or DOX a better dividend stock?

Does the media refer more to ACN or DOX?

Which has more risk & volatility, ACN or DOX?

Is ACN or DOX more profitable?

Do institutionals and insiders believe in ACN or DOX?

Do analysts recommend ACN or DOX?

Summary

How does Amdocs compare to Leidos?

Is DOX or LDOS a better dividend stock?

Which has stronger valuation & earnings, DOX or LDOS?

Do analysts prefer DOX or LDOS?

Does the media favor DOX or LDOS?

Which has more volatility & risk, DOX or LDOS?

Is DOX or LDOS more profitable?

Do insiders & institutionals believe in DOX or LDOS?

Summary

How does Amdocs compare to CACI International?

Is DOX or CACI more profitable?

Do analysts rate DOX or CACI?

Do institutionals and insiders have more ownership in DOX or CACI?

Which has higher valuation and earnings, DOX or CACI?

Does the media refer more to DOX or CACI?

Which has more risk & volatility, DOX or CACI?

Summary

How does Amdocs compare to Gartner?

Which has stronger valuation & earnings, IT or DOX?

Do institutionals & insiders believe in IT or DOX?

Does the media prefer IT or DOX?

Is IT or DOX more profitable?

Do analysts prefer IT or DOX?

Which has more risk & volatility, IT or DOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DOX vs. The Competition

Amdocs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools